id	sid	eid	entity	type
bptjm-33	1	1	berkeley pharma tech journal	ORG
bptjm-33	2	1	nft	ORG
bptjm-33	2	2	october 5	DATE
bptjm-33	2	3	2022	CARDINAL
bptjm-33	2	4	november 21	DATE
bptjm-33	2	5	2022	CARDINAL
bptjm-33	2	6	december 28	DATE
bptjm-33	2	7	2022	CARDINAL
bptjm-33	2	8	4.0	CARDINAL
bptjm-33	5	1	micrornas	PERSON
bptjm-33	8	1	william	PERSON
bptjm-33	8	2	gayoung yang	PERSON
bptjm-33	8	3	prakruti jajoo berkeley pharma tech journal	ORG
bptjm-33	8	4	49 1	DATE
bptjm-33	9	1	more than 5.5 million	CARDINAL
bptjm-33	9	2	the united states	GPE
bptjm-33	9	3	up to 80%	PERCENT
bptjm-33	9	4	overall1	ORG
bptjm-33	10	1	two	CARDINAL
bptjm-33	11	1	disease1	PERSON
bptjm-33	12	1	aβ38	ORG
bptjm-33	12	2	aβ40	PRODUCT
bptjm-33	12	3	aβ42	ORG
bptjm-33	12	4	cascade1	PERSON
bptjm-33	15	1	two	CARDINAL
bptjm-33	15	2	ad1	PERSON
bptjm-33	15	3	analysis1	GPE
bptjm-33	16	1	scenarios2	PRODUCT
bptjm-33	19	1	brain3	FAC
bptjm-33	20	1	berkeley pharma tech journal	ORG
bptjm-33	20	2	50	CARDINAL
bptjm-33	20	3	mmse)4	ORG
bptjm-33	21	1	nmda	PERSON
bptjm-33	21	2	brain3	LOC
bptjm-33	24	1	micrornas	PERSON
bptjm-33	25	1	approximately 22	CARDINAL
bptjm-33	25	2	body5	ORG
bptjm-33	26	1	apoptosis6	ORG
bptjm-33	27	1	mirna	PERSON
bptjm-33	27	2	up to	CARDINAL
bptjm-33	27	3	200 mrnas	QUANTITY
bptjm-33	27	4	cancer5	LOC
bptjm-33	28	1	mirna	PERSON
bptjm-33	29	1	approximately 70%	PERCENT
bptjm-33	29	2	mirna	PERSON
bptjm-33	29	3	states7	ORG
bptjm-33	30	1	synapses8	EVENT
bptjm-33	31	1	plasma9	GPE
bptjm-33	32	1	mirna	PERSON
bptjm-33	33	1	berkeley pharma tech journal	ORG
bptjm-33	33	2	51	CARDINAL
bptjm-33	34	1	2	CARDINAL
bptjm-33	34	2	2.1	CARDINAL
bptjm-33	36	1	two	CARDINAL
bptjm-33	37	1	aβ40	PRODUCT
bptjm-33	37	2	aβ42	PRODUCT
bptjm-33	38	1	aβ40	PRODUCT
bptjm-33	38	2	death11	ORG
bptjm-33	39	1	bace1	ORG
bptjm-33	40	1	42	CARDINAL
bptjm-33	40	2	aβ42	ORG
bptjm-33	41	1	aβ42	ORG
bptjm-33	41	2	toxicity10,11,12	CARDINAL
bptjm-33	46	1	berkeley pharma tech journal	ORG
bptjm-33	46	2	52 2.2	CARDINAL
bptjm-33	51	1	approximately 20	CARDINAL
bptjm-33	54	1	mirna-124 and	GPE
bptjm-33	57	1	mir-125b-5p	PERSON
bptjm-33	57	2	mir23b	ORG
bptjm-33	57	3	1 and 2(erk1/2	CARDINAL
bptjm-33	57	4	methylesterase-1	PERSON
bptjm-33	58	1	12	CARDINAL
bptjm-33	59	1	berkeley pharma tech journal	ORG
bptjm-33	59	2	53 2.3	CARDINAL
bptjm-33	61	1	scara1	ORG
bptjm-33	61	2	cd36	ORG
bptjm-33	61	3	cd14	ORG
bptjm-33	61	4	cd47	ORG
bptjm-33	62	1	il-1β	PERSON
bptjm-33	62	2	neuroinflammation7	ORG
bptjm-33	64	1	1	CARDINAL
bptjm-33	65	1	3	CARDINAL
bptjm-33	65	2	about 70%	PERCENT
bptjm-33	66	1	presenilin-2	PERSON
bptjm-33	66	2	1 (	CARDINAL
bptjm-33	66	3	3.1	CARDINAL
bptjm-33	67	1	21	CARDINAL
bptjm-33	68	1	twenty-five	CARDINAL
bptjm-33	68	2	thirty	CARDINAL
bptjm-33	69	1	berkeley pharma tech journal	ORG
bptjm-33	69	2	54	CARDINAL
bptjm-33	70	1	a673v	PERSON
bptjm-33	70	2	d678h	GPE
bptjm-33	70	3	d678n	GPE
bptjm-33	72	1	v717i	PERSON
bptjm-33	72	2	v717l	GPE
bptjm-33	72	3	l723p	PRODUCT
bptjm-33	72	4	k724n	ORG
bptjm-33	72	5	aβ42/aβ40	ORG
bptjm-33	73	1	e693k	GPE
bptjm-33	73	2	d694n	GPE
bptjm-33	74	1	one	CARDINAL
bptjm-33	74	2	aβ40	PRODUCT
bptjm-33	74	3	aβ42 secretion15	PERSON
bptjm-33	75	1	3.2	CARDINAL
bptjm-33	76	1	psen1	PERSON
bptjm-33	76	2	psen2	PERSON
bptjm-33	76	3	psen1	PERSON
bptjm-33	76	4	psen2	PERSON
bptjm-33	76	5	γ	GPE
bptjm-33	76	6	ad14	PRODUCT
bptjm-33	77	1	psen1	PERSON
bptjm-33	78	1	psen1	PERSON
bptjm-33	78	2	more than 200	CARDINAL
bptjm-33	79	1	less than 40	CARDINAL
bptjm-33	79	2	psen2	PERSON
bptjm-33	79	3	aβ42	PERSON
bptjm-33	79	4	aβ40	PRODUCT
bptjm-33	80	1	psen1	PERSON
bptjm-33	81	1	psen1	PERSON
bptjm-33	82	1	42/40	CARDINAL
bptjm-33	82	2	psen2	PERSON
bptjm-33	82	3	production15	PERSON
bptjm-33	83	1	3.3	CARDINAL
bptjm-33	84	1	apoe4	ORG
bptjm-33	86	1	19	CARDINAL
bptjm-33	86	2	three	CARDINAL
bptjm-33	86	3	apoe2	LOC
bptjm-33	86	4	apoe3	PERSON
bptjm-33	86	5	apoe4	ORG
bptjm-33	87	1	apoe4	ORG
bptjm-33	88	1	pharma tech journal	ORG
bptjm-33	88	2	55	DATE
bptjm-33	89	1	apoeε4	PERSON
bptjm-33	89	2	apoeε2	PERSON
bptjm-33	89	3	apoeε3	PERSON
bptjm-33	90	1	apoeε4	PERSON
bptjm-33	91	1	apoeε4	PERSON
bptjm-33	91	2	pathogenesis15	GPE
bptjm-33	92	1	3.4	CARDINAL
bptjm-33	92	2	clu	PERSON
bptjm-33	92	3	1 (	CARDINAL
bptjm-33	93	1	clu gene	PERSON
bptjm-33	93	2	8	CARDINAL
bptjm-33	95	1	hippocampus	GPE
bptjm-33	98	1	1	CARDINAL
bptjm-33	99	1	second	ORDINAL
bptjm-33	99	2	nft	ORG
bptjm-33	100	1	3.5	CARDINAL
bptjm-33	101	1	trem2 trem2	PERSON
bptjm-33	103	1	trem2	PERSON
bptjm-33	105	1	berkeley pharma tech journal	ORG
bptjm-33	105	2	56 4	DATE
bptjm-33	107	1	mirna	PERSON
bptjm-33	107	2	pathology16	GPE
bptjm-33	108	1	two	CARDINAL
bptjm-33	109	1	mirna	PERSON
bptjm-33	110	1	oligonucleotides17	PRODUCT
bptjm-33	112	1	one	CARDINAL
bptjm-33	112	2	swedish	NORP
bptjm-33	112	3	pathway18	GPE
bptjm-33	113	1	ad18	PRODUCT
bptjm-33	115	1	higaki et	ORG
bptjm-33	116	1	al	PERSON
bptjm-33	116	2	tg2576	GPE
bptjm-33	117	1	berkeley pharma tech journal	ORG
bptjm-33	117	2	57	CARDINAL
bptjm-33	119	1	al	ORG
bptjm-33	120	1	mir-124	PERSON
bptjm-33	120	2	1	CARDINAL
bptjm-33	120	3	bace1	ORG
bptjm-33	121	1	bace1	ORG
bptjm-33	122	1	bace1	ORG
bptjm-33	122	2	nft	ORG
bptjm-33	122	3	burden20	PERSON
bptjm-33	124	1	nft	ORG
bptjm-33	125	1	formation21	LANGUAGE
bptjm-33	126	1	5xfad	ORG
bptjm-33	126	2	pathways21	LOC
bptjm-33	128	1	1	CARDINAL
bptjm-33	128	2	berkeley pharma tech journal	ORG
bptjm-33	128	3	58	DATE
bptjm-33	128	4	mirna	PERSON
bptjm-33	129	1	mirna	PERSON
bptjm-33	129	2	vivo22	NORP
bptjm-33	130	1	mirna	PERSON
bptjm-33	130	2	mirna modulation23	PERSON
bptjm-33	132	1	mirna	PERSON
bptjm-33	132	2	bace1	ORG
bptjm-33	132	3	bace1	ORG
bptjm-33	133	1	bace1	ORG
bptjm-33	133	2	mci	ORG
bptjm-33	133	3	apoe4	ORG
bptjm-33	133	4	tau	PERSON
bptjm-33	133	5	5p	CARDINAL
bptjm-33	133	6	bace1	ORG
bptjm-33	133	7	mir-16-5p &	ORG
bptjm-33	133	8	5p	CARDINAL
bptjm-33	133	9	berkeley pharma tech journal	ORG
bptjm-33	133	10	59	CARDINAL
bptjm-33	133	11	5p	CARDINAL
bptjm-33	133	12	1	CARDINAL
bptjm-33	133	13	the relevant mirnas &	ORG
bptjm-33	133	14	5	CARDINAL
bptjm-33	133	15	5.1	CARDINAL
bptjm-33	135	1	first	ORDINAL
bptjm-33	135	2	protein25	GPE
bptjm-33	135	3	26	DATE
bptjm-33	138	1	ad24,25,27	DATE
bptjm-33	140	1	alzheimer’s25	DATE
bptjm-33	141	1	5.2	CARDINAL
bptjm-33	142	1	mirna	PERSON
bptjm-33	143	1	creation25	GPE
bptjm-33	144	1	mirna	PERSON
bptjm-33	146	1	mirna	PERSON
bptjm-33	147	1	5.3	CARDINAL
bptjm-33	147	2	mirna	PERSON
bptjm-33	148	1	mir-16	GPE
bptjm-33	148	2	berkeley pharma tech journal	ORG
bptjm-33	149	1	60	CARDINAL
bptjm-33	149	2	individuals27	GPE
bptjm-33	150	1	mir-34a5p	PERSON
bptjm-33	150	2	mir-16	GPE
bptjm-33	152	1	mci	ORG
bptjm-33	152	2	ad21	PRODUCT
bptjm-33	154	1	mir132/212	ORG
bptjm-33	154	2	disease26	ORG
bptjm-33	155	1	mirna	PERSON
bptjm-33	156	1	6	CARDINAL
bptjm-33	156	2	6.1	CARDINAL
bptjm-33	159	1	hsa	ORG
bptjm-33	159	2	hsa	ORG
bptjm-33	160	1	first	ORDINAL
bptjm-33	160	2	mirna	PERSON
bptjm-33	161	1	5′-utr	DATE
bptjm-33	163	1	berkeley pharma tech journal	ORG
bptjm-33	163	2	61	CARDINAL
bptjm-33	163	3	fe	GPE
bptjm-33	163	4	ad29	ORG
bptjm-33	164	1	mirna	PERSON
bptjm-33	165	1	6.2	CARDINAL
bptjm-33	166	1	hyperphosphorylated tau	PERSON
bptjm-33	166	2	disorders30	GPE
bptjm-33	169	1	ad30	PRODUCT
bptjm-33	171	1	6	CARDINAL
bptjm-33	171	2	2,3	CARDINAL
bptjm-33	171	3	10	CARDINAL
bptjm-33	172	1	mir-16	GPE
bptjm-33	172	2	mir132	PERSON
bptjm-33	172	3	10	CARDINAL
bptjm-33	172	4	10	CARDINAL
bptjm-33	173	1	mir-16	GPE
bptjm-33	174	1	6.3	TIME
bptjm-33	176	1	mir-31	ORG
bptjm-33	176	2	bace1	ORG
bptjm-33	177	1	17-month-old	DATE
bptjm-33	177	2	3xtg	CARDINAL
bptjm-33	177	3	berkeley pharma tech journal	ORG
bptjm-33	177	4	62	CARDINAL
bptjm-33	178	1	subiculum26	GPE
bptjm-33	179	1	mirnas	PERSON
bptjm-33	179	2	3′-utr	ORDINAL
bptjm-33	180	1	mirna	PERSON
bptjm-33	182	1	3’-utr	CARDINAL
bptjm-33	183	1	3	CARDINAL
bptjm-33	184	1	mirna	PERSON
bptjm-33	184	2	ad32	PRODUCT
bptjm-33	185	1	6.4	CARDINAL
bptjm-33	186	1	apoe4	ORG
bptjm-33	186	2	apoe4	ORG
bptjm-33	188	1	apoe4	ORG
bptjm-33	188	2	decline33	PRODUCT
bptjm-33	189	1	synaptojanin1	PERSON
bptjm-33	190	1	1	CARDINAL
bptjm-33	190	2	apoe4	ORG
bptjm-33	190	3	impairment33	GPE
bptjm-33	191	1	apoe4	ORG
bptjm-33	192	1	7	CARDINAL
bptjm-33	192	2	7.1	CARDINAL
bptjm-33	193	1	mirna	PERSON
bptjm-33	195	1	63	CARDINAL
bptjm-33	195	2	mirna	PERSON
bptjm-33	196	1	mirna	PERSON
bptjm-33	196	2	ad34	PRODUCT
bptjm-33	198	1	mirna	PERSON
bptjm-33	199	1	mirna	PERSON
bptjm-33	201	1	aβ34	ORG
bptjm-33	201	2	36	DATE
bptjm-33	203	1	ad34	PRODUCT
bptjm-33	204	1	7.2	CARDINAL
bptjm-33	205	1	mirna	PERSON
bptjm-33	205	2	mirna	PERSON
bptjm-33	205	3	collection34	GPE
bptjm-33	207	1	mir-127-3p	ORG
bptjm-33	209	1	only one	CARDINAL
bptjm-33	211	1	mirna	PERSON
bptjm-33	211	2	treatments37	ORG
bptjm-33	215	1	berkeley pharma tech journal	ORG
bptjm-33	215	2	64 7.3	CARDINAL
bptjm-33	216	1	mirna	PERSON
bptjm-33	217	1	mirna	PERSON
bptjm-33	218	1	one	CARDINAL
bptjm-33	218	2	one	CARDINAL
bptjm-33	218	3	mci	ORG
bptjm-33	219	1	mir134	GPE
bptjm-33	219	2	mir-38238	DATE
bptjm-33	220	1	china	GPE
bptjm-33	220	2	mirna	PERSON
bptjm-33	221	1	ad39	ORG
bptjm-33	222	1	8	CARDINAL
bptjm-33	223	1	8.1	CARDINAL
bptjm-33	224	1	mirna	PERSON
bptjm-33	224	2	one	CARDINAL
bptjm-33	224	3	mirna	PERSON
bptjm-33	225	1	mirna	PERSON
bptjm-33	225	2	cns40,41	ORG
bptjm-33	226	1	mirna	PERSON
bptjm-33	228	1	8.2	CARDINAL
bptjm-33	229	1	mirna	PERSON
bptjm-33	229	2	mirna	PERSON
bptjm-33	231	1	mirna	PERSON
bptjm-33	232	1	mirna	PERSON
bptjm-33	233	1	mirna	PERSON
bptjm-33	234	1	berkeley pharma tech journal	ORG
bptjm-33	234	2	65 9	DATE
bptjm-33	237	1	one	CARDINAL
bptjm-33	242	1	1	CARDINAL
bptjm-33	243	1	rahman	PERSON
bptjm-33	243	2	islam t	PERSON
bptjm-33	243	3	identi	PERSON
bptjm-33	246	1	august 1, 2019	DATE
bptjm-33	247	1	october 3	DATE
bptjm-33	247	2	2022	CARDINAL
bptjm-33	248	1	2	CARDINAL
bptjm-33	248	2	wu	PERSON
bptjm-33	248	3	cheng l	PERSON
bptjm-33	250	1	2020;12(1):59	CARDINAL
bptjm-33	251	1	2020	DATE
bptjm-33	251	2	may 15	DATE
bptjm-33	255	1	https://www.nia.nih.gov/health/how-alzheimersdisease-treated#:~:text=aducanumab%20is%20th e%20only%20disease	PERSON
bptjm-33	255	2	brain%20lesions%20associat ed%20with%20alzheimer%27s	GPE
bptjm-33	255	3	september 19	DATE
bptjm-33	255	4	2022	DATE
bptjm-33	256	1	4	CARDINAL
bptjm-33	256	2	grossberg gt	PERSON
bptjm-33	258	1	curr	PERSON
bptjm-33	258	2	clin	PERSON
bptjm-33	259	1	2003;64(4):216	CARDINAL
bptjm-33	259	2	doi:10.1016	PERSON
bptjm-33	260	1	angelucci	DATE
bptjm-33	261	1	cechova k	PERSON
bptjm-33	261	2	hort j. micrornas	PERSON
bptjm-33	264	1	january 1	DATE
bptjm-33	264	2	1ad	ORG
bptjm-33	265	1	september 19	DATE
bptjm-33	265	2	2022	CARDINAL
bptjm-33	266	1	6	CARDINAL
bptjm-33	266	2	wang y	PERSON
bptjm-33	266	3	zhao l	PERSON
bptjm-33	266	4	kan	ORG
bptjm-33	266	5	shi h	PERSON
bptjm-33	266	6	han j. mir-22	NORP
bptjm-33	269	1	2018	DATE
bptjm-33	270	1	september 19	DATE
bptjm-33	270	2	2022	CARDINAL
bptjm-33	271	1	7	CARDINAL
bptjm-33	271	2	adlakha yk	PERSON
bptjm-33	271	3	saini n.	PERSON
bptjm-33	272	1	4598	CARDINAL
bptjm-33	273	1	february 21, 2014	DATE
bptjm-33	274	1	september 19	DATE
bptjm-33	274	2	2022	CARDINAL
bptjm-33	275	1	reza-zaldivar	PERSON
bptjm-33	275	2	minjarez	PERSON
bptjm-33	276	1	microrna	CARDINAL
bptjm-33	278	1	2020;8:255	CARDINAL
bptjm-33	279	1	2020	DATE
bptjm-33	279	2	5	CARDINAL
bptjm-33	279	3	9	CARDINAL
bptjm-33	280	1	s. kumar	PERSON
bptjm-33	280	2	m. vijayan	PERSON
bptjm-33	280	3	j.s. bhatti	PERSON
bptjm-33	280	4	p.h. reddy	PERSON
bptjm-33	280	5	chapter three	LAW
bptjm-33	280	6	reddy	PERSON
bptjm-33	280	7	2017;146:47-94	CARDINAL
bptjm-33	280	8	1877-1173	CARDINAL
bptjm-33	280	9	9780128115329	DATE
bptjm-33	280	10	10	CARDINAL
bptjm-33	281	1	sun x	PERSON
bptjm-33	281	2	chen w-d	PERSON
bptjm-33	281	3	wang y-d.	PERSON
bptjm-33	283	1	https://www.frontiersin.org/articles/10.3389/fp	GPE
bptjm-33	283	2	har.2015.00221	DATE
bptjm-33	284	1	january 1	DATE
bptjm-33	284	2	1ad	ORG
bptjm-33	285	1	october 3	DATE
bptjm-33	285	2	2022	CARDINAL
bptjm-33	286	1	11	CARDINAL
bptjm-33	286	2	tiwari s	PERSON
bptjm-33	286	3	atluri	GPE
bptjm-33	286	4	kaushik a	ORG
bptjm-33	286	5	nair m. alzheimer's	PERSON
bptjm-33	287	1	j nanomedicine	PERSON
bptjm-33	288	1	2019;14:5541-5554	CARDINAL
bptjm-33	289	1	berkeley pharma tech journal	ORG
bptjm-33	289	2	66 2019	QUANTITY
bptjm-33	289	3	12	DATE
bptjm-33	290	1	breijyeh	PERSON
bptjm-33	292	1	2020	DATE
bptjm-33	292	2	25(24):5789	CARDINAL
bptjm-33	292	3	789 13	DATE
bptjm-33	293	1	sen liu	PERSON
bptjm-33	293	2	qiang zheng	PERSON
bptjm-33	293	3	shengwei hao	PERSON
bptjm-33	293	4	longjun yang	PERSON
bptjm-33	293	5	qingrong xia	PERSON
bptjm-33	293	6	congcong qi	PERSON
bptjm-33	293	7	jinfang ge	PERSON
bptjm-33	293	8	2022;148(112681	DATE
bptjm-33	294	1	issn 0753-3322	PERSON
bptjm-33	295	1	14	CARDINAL
bptjm-33	298	1	october 3	DATE
bptjm-33	298	2	2022	CARDINAL
bptjm-33	299	1	15	CARDINAL
bptjm-33	299	2	breijyeh	PERSON
bptjm-33	302	1	2020	DATE
bptjm-33	302	2	dec 8	DATE
bptjm-33	305	1	dabrowski k	PERSON
bptjm-33	307	1	https://www.sciencedirect.com/science/article	ORG
bptjm-33	308	1	august 9, 2021	DATE
bptjm-33	309	1	october 3	DATE
bptjm-33	309	2	2022	CARDINAL
bptjm-33	310	1	17	CARDINAL
bptjm-33	311	1	ishida m	PERSON
bptjm-33	312	1	curr	PERSON
bptjm-33	312	2	2013;1(1):63-70	CARDINAL
bptjm-33	314	1	jiang h	PERSON
bptjm-33	314	2	liu j	PERSON
bptjm-33	315	1	tau	PERSON
bptjm-33	319	1	april 18	DATE
bptjm-33	319	2	2022	CARDINAL
bptjm-33	320	1	october 3	DATE
bptjm-33	320	2	2022	CARDINAL
bptjm-33	321	1	19	CARDINAL
bptjm-33	322	1	higaki s	PERSON
bptjm-33	324	1	plos one	PERSON
bptjm-33	325	1	october 3	DATE
bptjm-33	325	2	2022	CARDINAL
bptjm-33	326	1	20	CARDINAL
bptjm-33	327	1	gong g	PERSON
bptjm-33	327	2	wang y	PERSON
bptjm-33	327	3	bian m	PERSON
bptjm-33	327	4	yu l	ORG
bptjm-33	327	5	wei c. mir-124	PERSON
bptjm-33	327	6	bace1	ORG
bptjm-33	329	1	2018	DATE
bptjm-33	329	2	15;9(37):24871	CARDINAL
bptjm-33	331	1	2017;8(69):114065-114071	DATE
bptjm-33	332	1	2017	CARDINAL
bptjm-33	332	2	dec 9	DATE
bptjm-33	332	3	doi:10.18632/oncotarget.23119 21	ORG
bptjm-33	333	1	ansari	PERSON
bptjm-33	333	2	milanesi e	PERSON
bptjm-33	337	1	june 21, 2019	DATE
bptjm-33	338	1	october 3	DATE
bptjm-33	338	2	2022	CARDINAL
bptjm-33	339	1	22	CARDINAL
bptjm-33	340	1	otsuka k	PERSON
bptjm-33	340	2	yamamoto y	PERSON
bptjm-33	340	3	ochiya t.	PERSON
bptjm-33	340	4	microrna	ORG
bptjm-33	340	5	hnrnpa1	LOC
bptjm-33	342	1	2018;9(37):24718-24730	CARDINAL
bptjm-33	343	1	2018	DATE
bptjm-33	344	1	dilsiz n. role	PERSON
bptjm-33	344	2	exosomal berkeley pharma tech journal	ORG
bptjm-33	344	3	67	CARDINAL
bptjm-33	345	1	sci oa	PERSON
bptjm-33	347	1	2020	DATE
bptjm-33	347	2	feb 26	DATE
bptjm-33	349	1	wang m	PERSON
bptjm-33	349	2	qin l	PERSON
bptjm-33	349	3	tang b. micrornas	PERSON
bptjm-33	351	1	2019;10:153	CARDINAL
bptjm-33	352	1	2019	CARDINAL
bptjm-33	352	2	fgene.2019.00153 25	DATE
bptjm-33	352	3	mukherjee	PERSON
bptjm-33	352	4	guha s	PERSON
bptjm-33	356	1	april 24, 2021	DATE
bptjm-33	357	1	october 3	DATE
bptjm-33	357	2	2022	CARDINAL
bptjm-33	358	1	26	CARDINAL
bptjm-33	359	1	barros-viegas	PERSON
bptjm-33	359	2	carmona v	PERSON
bptjm-33	359	3	bace1	ORG
bptjm-33	361	1	january 17, 2020	DATE
bptjm-33	362	1	october 3	DATE
bptjm-33	362	2	2022	CARDINAL
bptjm-33	363	1	27	CARDINAL
bptjm-33	364	1	li p	PERSON
bptjm-33	364	2	xu y	PERSON
bptjm-33	364	3	wang	PERSON
bptjm-33	364	4	huang j	PERSON
bptjm-33	364	5	li q. mir-34a-5p	PERSON
bptjm-33	364	6	bace1	ORG
bptjm-33	365	1	j neurol sci	PERSON
bptjm-33	365	2	2020;413:116793	CARDINAL
bptjm-33	366	1	doi:10.1016/j.jns.2020.116793 28	EVENT
bptjm-33	367	1	patel n	PERSON
bptjm-33	369	1	august 6, 2008	DATE
bptjm-33	370	1	october 3	DATE
bptjm-33	370	2	2022	CARDINAL
bptjm-33	371	1	29	CARDINAL
bptjm-33	372	1	jm	ORG
bptjm-33	372	2	maloney	ORG
bptjm-33	372	3	rogers jt	PERSON
bptjm-33	372	4	lahiri dk	PERSON
bptjm-33	374	1	66	CARDINAL
bptjm-33	375	1	november 23, 2018	DATE
bptjm-33	376	1	october 3	DATE
bptjm-33	376	2	2022	CARDINAL
bptjm-33	377	1	30	CARDINAL
bptjm-33	378	1	jiang h	PERSON
bptjm-33	378	2	liu j	PERSON
bptjm-33	379	1	tau	PERSON
bptjm-33	381	1	2022;28:539-557	CARDINAL
bptjm-33	382	1	2022	CARDINAL
bptjm-33	382	2	doi:10.1016/j.omtn.2022.04.008	GPE
bptjm-33	382	3	31	CARDINAL
bptjm-33	383	1	hébert ss	PERSON
bptjm-33	383	2	buée l. micrornas	PERSON
bptjm-33	385	1	06561/.	CARDINAL
bptjm-33	386	1	october 3	DATE
bptjm-33	386	2	2022	CARDINAL
bptjm-33	387	1	32	CARDINAL
bptjm-33	388	1	wang r	PERSON
bptjm-33	388	2	lahiri dk.	PERSON
bptjm-33	389	1	microrna-298	PERSON
bptjm-33	389	2	bace1	ORG
bptjm-33	389	3	3′-utr	LAW
bptjm-33	390	1	sci rep	ORG
bptjm-33	390	2	2022;12(3074	ORG
bptjm-33	391	1	33	CARDINAL
bptjm-33	392	1	cao j	PERSON
bptjm-33	392	2	huang m	PERSON
bptjm-33	392	3	guo l.	PERSON
bptjm-33	392	4	microrna-195	PERSON
bptjm-33	392	5	apoe4	ORG
bptjm-33	394	1	2021	CARDINAL
bptjm-33	395	1	26:4687–4701	CARDINAL
bptjm-33	396	1	34	CARDINAL
bptjm-33	397	1	weller j	ORG
bptjm-33	397	2	budson a.	PERSON
bptjm-33	400	1	2018 jul 31	DATE
bptjm-33	402	1	guo r	PERSON
bptjm-33	402	2	zhang j	PERSON
bptjm-33	403	1	9	CARDINAL
bptjm-33	403	2	berkeley pharma tech journal	ORG
bptjm-33	403	3	68	CARDINAL
bptjm-33	404	1	j alzheimers	PERSON
bptjm-33	406	1	doi:10.3233/jad-170343 36	DATE
bptjm-33	407	1	fu y	PERSON
bptjm-33	408	1	zheng	PERSON
bptjm-33	409	1	3p	CARDINAL
bptjm-33	410	1	metab brain dis	ORG
bptjm-33	411	1	2019;34(5):1355	CARDINAL
bptjm-33	413	1	yiannopoulou kg	PERSON
bptjm-33	413	2	papageorgiou sg	PERSON
bptjm-33	415	1	j cent nerv syst	ORG
bptjm-33	416	1	2020;12:1179573520907397	CARDINAL
bptjm-33	416	2	2020	DATE
bptjm-33	416	3	feb 29	DATE
bptjm-33	416	4	38	CARDINAL
bptjm-33	417	1	mirna	PERSON
bptjm-33	417	2	mci	ORG
bptjm-33	418	1	google	ORG
bptjm-33	419	1	47b2	DATE
bptjm-33	421	1	october 3	DATE
bptjm-33	421	2	2022	CARDINAL
bptjm-33	422	1	39	CARDINAL
bptjm-33	424	1	google	ORG
bptjm-33	426	1	october 3	DATE
bptjm-33	426	2	2022	CARDINAL
bptjm-33	427	1	40	CARDINAL
bptjm-33	428	1	ma n	PERSON
bptjm-33	428	2	zhang w	PERSON
bptjm-33	428	3	wan j.	PERSON
bptjm-33	429	1	ny	GPE
bptjm-33	430	1	2020;12(3):2897-2920	CARDINAL
bptjm-33	431	1	41	CARDINAL
bptjm-33	431	2	h.	PERSON
bptjm-33	431	3	zhou	PERSON
bptjm-33	431	4	l.	PERSON
bptjm-33	432	1	microrna	CARDINAL
bptjm-33	433	1	2021	CARDINAL
bptjm-33	434	1	https://doi.org/10.1186/s13024-021-00496-7 berkeley pharma tech journal	ORG
bptjm-33	434	2	69	CARDINAL